nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—CYP3A4—bone cancer	0.704	1	CbGaD
Fentanyl—Sufentanil—CYP3A4—bone cancer	0.000912	0.158	CrCbGaD
Fentanyl—Alfentanil—CYP3A4—bone cancer	0.000848	0.147	CrCbGaD
Fentanyl—Astemizole—CYP3A4—bone cancer	0.000659	0.114	CrCbGaD
Fentanyl—Darifenacin—CYP3A4—bone cancer	0.000483	0.0838	CrCbGaD
Fentanyl—Phenylbutazone—CYP3A4—bone cancer	0.000405	0.0703	CrCbGaD
Fentanyl—Phenylbutazone—PTGS2—bone cancer	0.000397	0.0688	CrCbGaD
Fentanyl—Propafenone—CYP3A4—bone cancer	0.000379	0.0657	CrCbGaD
Fentanyl—Modafinil—CYP3A4—bone cancer	0.000317	0.0551	CrCbGaD
Fentanyl—Dextropropoxyphene—CYP3A4—bone cancer	0.000314	0.0544	CrCbGaD
Fentanyl—Loperamide—CYP3A4—bone cancer	0.000299	0.0519	CrCbGaD
Fentanyl—Benzphetamine—CYP3A4—bone cancer	0.000275	0.0477	CrCbGaD
Fentanyl—Phenoxybenzamine—CYP3A4—bone cancer	0.000263	0.0456	CrCbGaD
Fentanyl—Methadone—CYP3A4—bone cancer	0.000213	0.0369	CrCbGaD
Fentanyl—CYP3A7—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000212	0.0647	CbGpPWpGaD
Fentanyl—Jaundice—Doxorubicin—bone cancer	0.000205	0.000712	CcSEcCtD
Fentanyl—Rhinitis—Epirubicin—bone cancer	0.000204	0.00071	CcSEcCtD
Fentanyl—Urinary tract infection—Doxorubicin—bone cancer	0.000204	0.00071	CcSEcCtD
Fentanyl—Conjunctivitis—Doxorubicin—bone cancer	0.000204	0.00071	CcSEcCtD
Fentanyl—Haemorrhage—Epirubicin—bone cancer	0.000204	0.000709	CcSEcCtD
Fentanyl—Eye disorder—Methotrexate—bone cancer	0.000203	0.000708	CcSEcCtD
Fentanyl—Tinnitus—Methotrexate—bone cancer	0.000203	0.000706	CcSEcCtD
Fentanyl—Hypoaesthesia—Epirubicin—bone cancer	0.000203	0.000705	CcSEcCtD
Fentanyl—Asthenia—Cisplatin—bone cancer	0.000202	0.000703	CcSEcCtD
Fentanyl—Pharyngitis—Epirubicin—bone cancer	0.000202	0.000703	CcSEcCtD
Fentanyl—Cardiac disorder—Methotrexate—bone cancer	0.000202	0.000703	CcSEcCtD
Fentanyl—Sweating—Doxorubicin—bone cancer	0.000201	0.0007	CcSEcCtD
Fentanyl—Urinary tract disorder—Epirubicin—bone cancer	0.000201	0.0007	CcSEcCtD
Fentanyl—Oedema peripheral—Epirubicin—bone cancer	0.000201	0.000698	CcSEcCtD
Fentanyl—Haematuria—Doxorubicin—bone cancer	0.0002	0.000696	CcSEcCtD
Fentanyl—Connective tissue disorder—Epirubicin—bone cancer	0.0002	0.000696	CcSEcCtD
Fentanyl—Urethral disorder—Epirubicin—bone cancer	0.0002	0.000695	CcSEcCtD
Fentanyl—Hepatobiliary disease—Doxorubicin—bone cancer	0.000198	0.000691	CcSEcCtD
Fentanyl—Epistaxis—Doxorubicin—bone cancer	0.000198	0.000689	CcSEcCtD
Fentanyl—Angiopathy—Methotrexate—bone cancer	0.000197	0.000687	CcSEcCtD
Fentanyl—Sinusitis—Doxorubicin—bone cancer	0.000197	0.000685	CcSEcCtD
Fentanyl—Immune system disorder—Methotrexate—bone cancer	0.000196	0.000684	CcSEcCtD
Fentanyl—Visual impairment—Epirubicin—bone cancer	0.000196	0.000683	CcSEcCtD
Fentanyl—Mediastinal disorder—Methotrexate—bone cancer	0.000196	0.000683	CcSEcCtD
Fentanyl—Chills—Methotrexate—bone cancer	0.000195	0.000679	CcSEcCtD
Fentanyl—Diarrhoea—Cisplatin—bone cancer	0.000193	0.000671	CcSEcCtD
Fentanyl—Erythema multiforme—Epirubicin—bone cancer	0.000192	0.00067	CcSEcCtD
Fentanyl—Alopecia—Methotrexate—bone cancer	0.000192	0.000669	CcSEcCtD
Fentanyl—Bradycardia—Doxorubicin—bone cancer	0.000192	0.000668	CcSEcCtD
Fentanyl—Mental disorder—Methotrexate—bone cancer	0.000191	0.000663	CcSEcCtD
Fentanyl—Eye disorder—Epirubicin—bone cancer	0.00019	0.000662	CcSEcCtD
Fentanyl—Tinnitus—Epirubicin—bone cancer	0.00019	0.000661	CcSEcCtD
Fentanyl—Erythema—Methotrexate—bone cancer	0.000189	0.000659	CcSEcCtD
Fentanyl—Malnutrition—Methotrexate—bone cancer	0.000189	0.000659	CcSEcCtD
Fentanyl—Haemoglobin—Doxorubicin—bone cancer	0.000189	0.000659	CcSEcCtD
Fentanyl—Cardiac disorder—Epirubicin—bone cancer	0.000189	0.000658	CcSEcCtD
Fentanyl—Flushing—Epirubicin—bone cancer	0.000189	0.000658	CcSEcCtD
Fentanyl—Rhinitis—Doxorubicin—bone cancer	0.000189	0.000657	CcSEcCtD
Fentanyl—Haemorrhage—Doxorubicin—bone cancer	0.000188	0.000656	CcSEcCtD
Fentanyl—Hypoaesthesia—Doxorubicin—bone cancer	0.000187	0.000652	CcSEcCtD
Fentanyl—Pharyngitis—Doxorubicin—bone cancer	0.000187	0.000651	CcSEcCtD
Fentanyl—Urinary tract disorder—Doxorubicin—bone cancer	0.000186	0.000648	CcSEcCtD
Fentanyl—Oedema peripheral—Doxorubicin—bone cancer	0.000186	0.000646	CcSEcCtD
Fentanyl—Dysgeusia—Methotrexate—bone cancer	0.000185	0.000646	CcSEcCtD
Fentanyl—Connective tissue disorder—Doxorubicin—bone cancer	0.000185	0.000644	CcSEcCtD
Fentanyl—Angiopathy—Epirubicin—bone cancer	0.000185	0.000643	CcSEcCtD
Fentanyl—Urethral disorder—Doxorubicin—bone cancer	0.000185	0.000643	CcSEcCtD
Fentanyl—Immune system disorder—Epirubicin—bone cancer	0.000184	0.00064	CcSEcCtD
Fentanyl—Mediastinal disorder—Epirubicin—bone cancer	0.000183	0.000639	CcSEcCtD
Fentanyl—Back pain—Methotrexate—bone cancer	0.000183	0.000638	CcSEcCtD
Fentanyl—Chills—Epirubicin—bone cancer	0.000183	0.000636	CcSEcCtD
Fentanyl—Arrhythmia—Epirubicin—bone cancer	0.000182	0.000633	CcSEcCtD
Fentanyl—Visual impairment—Doxorubicin—bone cancer	0.000182	0.000632	CcSEcCtD
Fentanyl—Alopecia—Epirubicin—bone cancer	0.00018	0.000626	CcSEcCtD
Fentanyl—Vomiting—Cisplatin—bone cancer	0.000179	0.000623	CcSEcCtD
Fentanyl—Vision blurred—Methotrexate—bone cancer	0.000178	0.000621	CcSEcCtD
Fentanyl—Mental disorder—Epirubicin—bone cancer	0.000178	0.000621	CcSEcCtD
Fentanyl—Erythema multiforme—Doxorubicin—bone cancer	0.000178	0.00062	CcSEcCtD
Fentanyl—Rash—Cisplatin—bone cancer	0.000178	0.000618	CcSEcCtD
Fentanyl—Dermatitis—Cisplatin—bone cancer	0.000177	0.000618	CcSEcCtD
Fentanyl—Malnutrition—Epirubicin—bone cancer	0.000177	0.000617	CcSEcCtD
Fentanyl—Erythema—Epirubicin—bone cancer	0.000177	0.000617	CcSEcCtD
Fentanyl—Eye disorder—Doxorubicin—bone cancer	0.000176	0.000613	CcSEcCtD
Fentanyl—Ill-defined disorder—Methotrexate—bone cancer	0.000176	0.000612	CcSEcCtD
Fentanyl—Tinnitus—Doxorubicin—bone cancer	0.000176	0.000611	CcSEcCtD
Fentanyl—Anaemia—Methotrexate—bone cancer	0.000175	0.000609	CcSEcCtD
Fentanyl—Flushing—Doxorubicin—bone cancer	0.000175	0.000609	CcSEcCtD
Fentanyl—Cardiac disorder—Doxorubicin—bone cancer	0.000175	0.000609	CcSEcCtD
Fentanyl—Flatulence—Epirubicin—bone cancer	0.000175	0.000608	CcSEcCtD
Fentanyl—Tension—Epirubicin—bone cancer	0.000174	0.000605	CcSEcCtD
Fentanyl—Dysgeusia—Epirubicin—bone cancer	0.000174	0.000604	CcSEcCtD
Fentanyl—Nervousness—Epirubicin—bone cancer	0.000172	0.000599	CcSEcCtD
Fentanyl—Back pain—Epirubicin—bone cancer	0.000171	0.000597	CcSEcCtD
Fentanyl—Angiopathy—Doxorubicin—bone cancer	0.000171	0.000595	CcSEcCtD
Fentanyl—Malaise—Methotrexate—bone cancer	0.000171	0.000594	CcSEcCtD
Fentanyl—Muscle spasms—Epirubicin—bone cancer	0.00017	0.000593	CcSEcCtD
Fentanyl—Immune system disorder—Doxorubicin—bone cancer	0.00017	0.000592	CcSEcCtD
Fentanyl—Vertigo—Methotrexate—bone cancer	0.00017	0.000592	CcSEcCtD
Fentanyl—Mediastinal disorder—Doxorubicin—bone cancer	0.00017	0.000591	CcSEcCtD
Fentanyl—Leukopenia—Methotrexate—bone cancer	0.000169	0.00059	CcSEcCtD
Fentanyl—Chills—Doxorubicin—bone cancer	0.000169	0.000588	CcSEcCtD
Fentanyl—Arrhythmia—Doxorubicin—bone cancer	0.000168	0.000586	CcSEcCtD
Fentanyl—Nausea—Cisplatin—bone cancer	0.000167	0.000582	CcSEcCtD
Fentanyl—Vision blurred—Epirubicin—bone cancer	0.000167	0.000581	CcSEcCtD
Fentanyl—Alopecia—Doxorubicin—bone cancer	0.000166	0.000579	CcSEcCtD
Fentanyl—Cough—Methotrexate—bone cancer	0.000165	0.000575	CcSEcCtD
Fentanyl—Mental disorder—Doxorubicin—bone cancer	0.000165	0.000574	CcSEcCtD
Fentanyl—Ill-defined disorder—Epirubicin—bone cancer	0.000164	0.000572	CcSEcCtD
Fentanyl—Convulsion—Methotrexate—bone cancer	0.000164	0.000571	CcSEcCtD
Fentanyl—Erythema—Doxorubicin—bone cancer	0.000164	0.000571	CcSEcCtD
Fentanyl—Malnutrition—Doxorubicin—bone cancer	0.000164	0.000571	CcSEcCtD
Fentanyl—Anaemia—Epirubicin—bone cancer	0.000164	0.00057	CcSEcCtD
Fentanyl—Agitation—Epirubicin—bone cancer	0.000163	0.000567	CcSEcCtD
Fentanyl—Flatulence—Doxorubicin—bone cancer	0.000162	0.000562	CcSEcCtD
Fentanyl—Arthralgia—Methotrexate—bone cancer	0.000161	0.000561	CcSEcCtD
Fentanyl—Myalgia—Methotrexate—bone cancer	0.000161	0.000561	CcSEcCtD
Fentanyl—Chest pain—Methotrexate—bone cancer	0.000161	0.000561	CcSEcCtD
Fentanyl—Tension—Doxorubicin—bone cancer	0.000161	0.00056	CcSEcCtD
Fentanyl—Dysgeusia—Doxorubicin—bone cancer	0.000161	0.000559	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00016	0.000557	CcSEcCtD
Fentanyl—Malaise—Epirubicin—bone cancer	0.00016	0.000556	CcSEcCtD
Fentanyl—Discomfort—Methotrexate—bone cancer	0.000159	0.000555	CcSEcCtD
Fentanyl—Nervousness—Doxorubicin—bone cancer	0.000159	0.000554	CcSEcCtD
Fentanyl—Vertigo—Epirubicin—bone cancer	0.000159	0.000554	CcSEcCtD
Fentanyl—Syncope—Epirubicin—bone cancer	0.000159	0.000553	CcSEcCtD
Fentanyl—Leukopenia—Epirubicin—bone cancer	0.000159	0.000552	CcSEcCtD
Fentanyl—Back pain—Doxorubicin—bone cancer	0.000159	0.000552	CcSEcCtD
Fentanyl—Muscle spasms—Doxorubicin—bone cancer	0.000158	0.000549	CcSEcCtD
Fentanyl—Palpitations—Epirubicin—bone cancer	0.000157	0.000545	CcSEcCtD
Fentanyl—Confusional state—Methotrexate—bone cancer	0.000156	0.000542	CcSEcCtD
Fentanyl—Loss of consciousness—Epirubicin—bone cancer	0.000156	0.000542	CcSEcCtD
Fentanyl—Cough—Epirubicin—bone cancer	0.000155	0.000538	CcSEcCtD
Fentanyl—Anaphylactic shock—Methotrexate—bone cancer	0.000155	0.000538	CcSEcCtD
Fentanyl—Vision blurred—Doxorubicin—bone cancer	0.000155	0.000538	CcSEcCtD
Fentanyl—Convulsion—Epirubicin—bone cancer	0.000154	0.000535	CcSEcCtD
Fentanyl—Infection—Methotrexate—bone cancer	0.000154	0.000535	CcSEcCtD
Fentanyl—CYP3A5—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000153	0.0468	CbGpPWpGaD
Fentanyl—Hypertension—Epirubicin—bone cancer	0.000153	0.000533	CcSEcCtD
Fentanyl—Ill-defined disorder—Doxorubicin—bone cancer	0.000152	0.00053	CcSEcCtD
Fentanyl—Nervous system disorder—Methotrexate—bone cancer	0.000152	0.000528	CcSEcCtD
Fentanyl—Anaemia—Doxorubicin—bone cancer	0.000152	0.000528	CcSEcCtD
Fentanyl—Thrombocytopenia—Methotrexate—bone cancer	0.000151	0.000527	CcSEcCtD
Fentanyl—Chest pain—Epirubicin—bone cancer	0.000151	0.000525	CcSEcCtD
Fentanyl—Myalgia—Epirubicin—bone cancer	0.000151	0.000525	CcSEcCtD
Fentanyl—Arthralgia—Epirubicin—bone cancer	0.000151	0.000525	CcSEcCtD
Fentanyl—Agitation—Doxorubicin—bone cancer	0.000151	0.000525	CcSEcCtD
Fentanyl—Anxiety—Epirubicin—bone cancer	0.00015	0.000523	CcSEcCtD
Fentanyl—Skin disorder—Methotrexate—bone cancer	0.00015	0.000523	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00015	0.000522	CcSEcCtD
Fentanyl—Hyperhidrosis—Methotrexate—bone cancer	0.000149	0.00052	CcSEcCtD
Fentanyl—Discomfort—Epirubicin—bone cancer	0.000149	0.000519	CcSEcCtD
Fentanyl—Malaise—Doxorubicin—bone cancer	0.000148	0.000515	CcSEcCtD
Fentanyl—Dry mouth—Epirubicin—bone cancer	0.000148	0.000514	CcSEcCtD
Fentanyl—Vertigo—Doxorubicin—bone cancer	0.000147	0.000513	CcSEcCtD
Fentanyl—Anorexia—Methotrexate—bone cancer	0.000147	0.000513	CcSEcCtD
Fentanyl—Syncope—Doxorubicin—bone cancer	0.000147	0.000512	CcSEcCtD
Fentanyl—Leukopenia—Doxorubicin—bone cancer	0.000147	0.000511	CcSEcCtD
Fentanyl—Confusional state—Epirubicin—bone cancer	0.000146	0.000508	CcSEcCtD
Fentanyl—Palpitations—Doxorubicin—bone cancer	0.000145	0.000504	CcSEcCtD
Fentanyl—Oedema—Epirubicin—bone cancer	0.000145	0.000503	CcSEcCtD
Fentanyl—Anaphylactic shock—Epirubicin—bone cancer	0.000145	0.000503	CcSEcCtD
Fentanyl—Hypotension—Methotrexate—bone cancer	0.000144	0.000503	CcSEcCtD
Fentanyl—Loss of consciousness—Doxorubicin—bone cancer	0.000144	0.000502	CcSEcCtD
Fentanyl—Infection—Epirubicin—bone cancer	0.000144	0.0005	CcSEcCtD
Fentanyl—Cough—Doxorubicin—bone cancer	0.000143	0.000498	CcSEcCtD
Fentanyl—Shock—Epirubicin—bone cancer	0.000142	0.000495	CcSEcCtD
Fentanyl—Convulsion—Doxorubicin—bone cancer	0.000142	0.000495	CcSEcCtD
Fentanyl—Nervous system disorder—Epirubicin—bone cancer	0.000142	0.000494	CcSEcCtD
Fentanyl—Thrombocytopenia—Epirubicin—bone cancer	0.000142	0.000493	CcSEcCtD
Fentanyl—Hypertension—Doxorubicin—bone cancer	0.000142	0.000493	CcSEcCtD
Fentanyl—Tachycardia—Epirubicin—bone cancer	0.000141	0.000491	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000141	0.00049	CcSEcCtD
Fentanyl—Skin disorder—Epirubicin—bone cancer	0.00014	0.000489	CcSEcCtD
Fentanyl—Hyperhidrosis—Epirubicin—bone cancer	0.00014	0.000487	CcSEcCtD
Fentanyl—Insomnia—Methotrexate—bone cancer	0.00014	0.000487	CcSEcCtD
Fentanyl—Myalgia—Doxorubicin—bone cancer	0.00014	0.000486	CcSEcCtD
Fentanyl—Arthralgia—Doxorubicin—bone cancer	0.00014	0.000486	CcSEcCtD
Fentanyl—Chest pain—Doxorubicin—bone cancer	0.00014	0.000486	CcSEcCtD
Fentanyl—Anxiety—Doxorubicin—bone cancer	0.000139	0.000484	CcSEcCtD
Fentanyl—Paraesthesia—Methotrexate—bone cancer	0.000139	0.000483	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000139	0.000483	CcSEcCtD
Fentanyl—Discomfort—Doxorubicin—bone cancer	0.000138	0.00048	CcSEcCtD
Fentanyl—Anorexia—Epirubicin—bone cancer	0.000138	0.00048	CcSEcCtD
Fentanyl—Dyspnoea—Methotrexate—bone cancer	0.000138	0.00048	CcSEcCtD
Fentanyl—Somnolence—Methotrexate—bone cancer	0.000137	0.000478	CcSEcCtD
Fentanyl—Dry mouth—Doxorubicin—bone cancer	0.000137	0.000475	CcSEcCtD
Fentanyl—Dyspepsia—Methotrexate—bone cancer	0.000136	0.000474	CcSEcCtD
Fentanyl—Hypotension—Epirubicin—bone cancer	0.000135	0.00047	CcSEcCtD
Fentanyl—Confusional state—Doxorubicin—bone cancer	0.000135	0.00047	CcSEcCtD
Fentanyl—Decreased appetite—Methotrexate—bone cancer	0.000134	0.000468	CcSEcCtD
Fentanyl—Oedema—Doxorubicin—bone cancer	0.000134	0.000466	CcSEcCtD
Fentanyl—Anaphylactic shock—Doxorubicin—bone cancer	0.000134	0.000466	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Methotrexate—bone cancer	0.000133	0.000464	CcSEcCtD
Fentanyl—Fatigue—Methotrexate—bone cancer	0.000133	0.000464	CcSEcCtD
Fentanyl—Infection—Doxorubicin—bone cancer	0.000133	0.000463	CcSEcCtD
Fentanyl—Pain—Methotrexate—bone cancer	0.000132	0.00046	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000132	0.000459	CcSEcCtD
Fentanyl—Shock—Doxorubicin—bone cancer	0.000132	0.000458	CcSEcCtD
Fentanyl—Nervous system disorder—Doxorubicin—bone cancer	0.000131	0.000457	CcSEcCtD
Fentanyl—Thrombocytopenia—Doxorubicin—bone cancer	0.000131	0.000456	CcSEcCtD
Fentanyl—Insomnia—Epirubicin—bone cancer	0.000131	0.000455	CcSEcCtD
Fentanyl—Tachycardia—Doxorubicin—bone cancer	0.000131	0.000455	CcSEcCtD
Fentanyl—Skin disorder—Doxorubicin—bone cancer	0.00013	0.000453	CcSEcCtD
Fentanyl—Paraesthesia—Epirubicin—bone cancer	0.00013	0.000452	CcSEcCtD
Fentanyl—Hyperhidrosis—Doxorubicin—bone cancer	0.000129	0.00045	CcSEcCtD
Fentanyl—Dyspnoea—Epirubicin—bone cancer	0.000129	0.000449	CcSEcCtD
Fentanyl—Somnolence—Epirubicin—bone cancer	0.000129	0.000448	CcSEcCtD
Fentanyl—Anorexia—Doxorubicin—bone cancer	0.000128	0.000444	CcSEcCtD
Fentanyl—Feeling abnormal—Methotrexate—bone cancer	0.000127	0.000443	CcSEcCtD
Fentanyl—Dyspepsia—Epirubicin—bone cancer	0.000127	0.000443	CcSEcCtD
Fentanyl—Gastrointestinal pain—Methotrexate—bone cancer	0.000126	0.00044	CcSEcCtD
Fentanyl—Decreased appetite—Epirubicin—bone cancer	0.000126	0.000438	CcSEcCtD
Fentanyl—Hypotension—Doxorubicin—bone cancer	0.000125	0.000435	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Epirubicin—bone cancer	0.000125	0.000435	CcSEcCtD
Fentanyl—Fatigue—Epirubicin—bone cancer	0.000125	0.000434	CcSEcCtD
Fentanyl—Constipation—Epirubicin—bone cancer	0.000124	0.000431	CcSEcCtD
Fentanyl—Pain—Epirubicin—bone cancer	0.000124	0.000431	CcSEcCtD
Fentanyl—Urticaria—Methotrexate—bone cancer	0.000123	0.000427	CcSEcCtD
Fentanyl—Abdominal pain—Methotrexate—bone cancer	0.000122	0.000425	CcSEcCtD
Fentanyl—Body temperature increased—Methotrexate—bone cancer	0.000122	0.000425	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000122	0.000424	CcSEcCtD
Fentanyl—Insomnia—Doxorubicin—bone cancer	0.000121	0.000421	CcSEcCtD
Fentanyl—Paraesthesia—Doxorubicin—bone cancer	0.00012	0.000418	CcSEcCtD
Fentanyl—Dyspnoea—Doxorubicin—bone cancer	0.000119	0.000415	CcSEcCtD
Fentanyl—Feeling abnormal—Epirubicin—bone cancer	0.000119	0.000415	CcSEcCtD
Fentanyl—Somnolence—Doxorubicin—bone cancer	0.000119	0.000414	CcSEcCtD
Fentanyl—Gastrointestinal pain—Epirubicin—bone cancer	0.000118	0.000412	CcSEcCtD
Fentanyl—Dyspepsia—Doxorubicin—bone cancer	0.000118	0.00041	CcSEcCtD
Fentanyl—Decreased appetite—Doxorubicin—bone cancer	0.000116	0.000405	CcSEcCtD
Fentanyl—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000116	0.0355	CbGpPWpGaD
Fentanyl—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000116	0.000402	CcSEcCtD
Fentanyl—Fatigue—Doxorubicin—bone cancer	0.000115	0.000402	CcSEcCtD
Fentanyl—Urticaria—Epirubicin—bone cancer	0.000115	0.0004	CcSEcCtD
Fentanyl—Constipation—Doxorubicin—bone cancer	0.000114	0.000398	CcSEcCtD
Fentanyl—Pain—Doxorubicin—bone cancer	0.000114	0.000398	CcSEcCtD
Fentanyl—Body temperature increased—Epirubicin—bone cancer	0.000114	0.000398	CcSEcCtD
Fentanyl—Abdominal pain—Epirubicin—bone cancer	0.000114	0.000398	CcSEcCtD
Fentanyl—Hypersensitivity—Methotrexate—bone cancer	0.000114	0.000396	CcSEcCtD
Fentanyl—Asthenia—Methotrexate—bone cancer	0.000111	0.000386	CcSEcCtD
Fentanyl—Feeling abnormal—Doxorubicin—bone cancer	0.00011	0.000384	CcSEcCtD
Fentanyl—Gastrointestinal pain—Doxorubicin—bone cancer	0.000109	0.000381	CcSEcCtD
Fentanyl—Pruritus—Methotrexate—bone cancer	0.000109	0.000381	CcSEcCtD
Fentanyl—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000109	0.0332	CbGpPWpGaD
Fentanyl—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.000108	0.0332	CbGpPWpGaD
Fentanyl—Hypersensitivity—Epirubicin—bone cancer	0.000107	0.000371	CcSEcCtD
Fentanyl—Urticaria—Doxorubicin—bone cancer	0.000106	0.00037	CcSEcCtD
Fentanyl—Body temperature increased—Doxorubicin—bone cancer	0.000106	0.000368	CcSEcCtD
Fentanyl—Abdominal pain—Doxorubicin—bone cancer	0.000106	0.000368	CcSEcCtD
Fentanyl—Diarrhoea—Methotrexate—bone cancer	0.000106	0.000368	CcSEcCtD
Fentanyl—Asthenia—Epirubicin—bone cancer	0.000104	0.000361	CcSEcCtD
Fentanyl—Pruritus—Epirubicin—bone cancer	0.000102	0.000356	CcSEcCtD
Fentanyl—CYP3A7—Xenobiotics—CYP3A4—bone cancer	0.000102	0.0312	CbGpPWpGaD
Fentanyl—Dizziness—Methotrexate—bone cancer	0.000102	0.000356	CcSEcCtD
Fentanyl—Diarrhoea—Epirubicin—bone cancer	9.9e-05	0.000344	CcSEcCtD
Fentanyl—Hypersensitivity—Doxorubicin—bone cancer	9.86e-05	0.000343	CcSEcCtD
Fentanyl—CYP3A5—Irinotecan Pathway—CYP3A4—bone cancer	9.83e-05	0.03	CbGpPWpGaD
Fentanyl—Vomiting—Methotrexate—bone cancer	9.83e-05	0.000342	CcSEcCtD
Fentanyl—Rash—Methotrexate—bone cancer	9.74e-05	0.000339	CcSEcCtD
Fentanyl—Dermatitis—Methotrexate—bone cancer	9.73e-05	0.000339	CcSEcCtD
Fentanyl—Headache—Methotrexate—bone cancer	9.68e-05	0.000337	CcSEcCtD
Fentanyl—Asthenia—Doxorubicin—bone cancer	9.6e-05	0.000334	CcSEcCtD
Fentanyl—Dizziness—Epirubicin—bone cancer	9.56e-05	0.000333	CcSEcCtD
Fentanyl—Pruritus—Doxorubicin—bone cancer	9.47e-05	0.00033	CcSEcCtD
Fentanyl—Vomiting—Epirubicin—bone cancer	9.2e-05	0.00032	CcSEcCtD
Fentanyl—Nausea—Methotrexate—bone cancer	9.18e-05	0.00032	CcSEcCtD
Fentanyl—Diarrhoea—Doxorubicin—bone cancer	9.16e-05	0.000319	CcSEcCtD
Fentanyl—Rash—Epirubicin—bone cancer	9.12e-05	0.000317	CcSEcCtD
Fentanyl—CYP3A7—Metapathway biotransformation—CYP4V2—bone cancer	9.11e-05	0.0279	CbGpPWpGaD
Fentanyl—Dermatitis—Epirubicin—bone cancer	9.11e-05	0.000317	CcSEcCtD
Fentanyl—Headache—Epirubicin—bone cancer	9.06e-05	0.000315	CcSEcCtD
Fentanyl—Dizziness—Doxorubicin—bone cancer	8.85e-05	0.000308	CcSEcCtD
Fentanyl—Nausea—Epirubicin—bone cancer	8.59e-05	0.000299	CcSEcCtD
Fentanyl—Vomiting—Doxorubicin—bone cancer	8.51e-05	0.000296	CcSEcCtD
Fentanyl—Rash—Doxorubicin—bone cancer	8.44e-05	0.000294	CcSEcCtD
Fentanyl—Dermatitis—Doxorubicin—bone cancer	8.43e-05	0.000293	CcSEcCtD
Fentanyl—Headache—Doxorubicin—bone cancer	8.38e-05	0.000292	CcSEcCtD
Fentanyl—Nausea—Doxorubicin—bone cancer	7.95e-05	0.000277	CcSEcCtD
Fentanyl—CYP3A5—Aflatoxin activation and detoxification—CYP3A4—bone cancer	7.7e-05	0.0235	CbGpPWpGaD
Fentanyl—OPRK1—Mecp2 and Associated Rett Syndrome—EZH2—bone cancer	7.66e-05	0.0234	CbGpPWpGaD
Fentanyl—CYP3A5—Xenobiotics—CYP3A4—bone cancer	7.39e-05	0.0226	CbGpPWpGaD
Fentanyl—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	7.12e-05	0.0218	CbGpPWpGaD
Fentanyl—CYP3A5—Tamoxifen metabolism—CYP3A4—bone cancer	7.1e-05	0.0217	CbGpPWpGaD
Fentanyl—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	6.7e-05	0.0205	CbGpPWpGaD
Fentanyl—CYP3A5—Metapathway biotransformation—CYP4V2—bone cancer	6.59e-05	0.0201	CbGpPWpGaD
Fentanyl—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	6.35e-05	0.0194	CbGpPWpGaD
Fentanyl—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	6.24e-05	0.0191	CbGpPWpGaD
Fentanyl—CYP3A5—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	5.07e-05	0.0155	CbGpPWpGaD
Fentanyl—OPRD1—G alpha (i) signalling events—RGS1—bone cancer	4.41e-05	0.0135	CbGpPWpGaD
Fentanyl—OPRD1—G alpha (i) signalling events—GRM4—bone cancer	4.41e-05	0.0135	CbGpPWpGaD
Fentanyl—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	4.24e-05	0.013	CbGpPWpGaD
Fentanyl—CYP3A7—Oxidation by Cytochrome P450—CYP3A4—bone cancer	4.19e-05	0.0128	CbGpPWpGaD
Fentanyl—OPRK1—G alpha (i) signalling events—RGS1—bone cancer	3.87e-05	0.0118	CbGpPWpGaD
Fentanyl—OPRK1—G alpha (i) signalling events—GRM4—bone cancer	3.87e-05	0.0118	CbGpPWpGaD
Fentanyl—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	3.85e-05	0.0118	CbGpPWpGaD
Fentanyl—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	3.83e-05	0.0117	CbGpPWpGaD
Fentanyl—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	3.65e-05	0.0111	CbGpPWpGaD
Fentanyl—CYP3A7—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	3.44e-05	0.0105	CbGpPWpGaD
Fentanyl—OPRM1—G alpha (i) signalling events—GRM4—bone cancer	3.27e-05	0.00999	CbGpPWpGaD
Fentanyl—OPRM1—G alpha (i) signalling events—RGS1—bone cancer	3.27e-05	0.00999	CbGpPWpGaD
Fentanyl—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	3.07e-05	0.00938	CbGpPWpGaD
Fentanyl—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	3.06e-05	0.00936	CbGpPWpGaD
Fentanyl—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	3.03e-05	0.00925	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—GRM4—bone cancer	2.67e-05	0.00816	CbGpPWpGaD
Fentanyl—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	2.49e-05	0.0076	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—GRM4—bone cancer	2.34e-05	0.00716	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—GRM1—bone cancer	2.31e-05	0.00708	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—GRM1—bone cancer	2.03e-05	0.0062	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—GRM4—bone cancer	1.98e-05	0.00605	CbGpPWpGaD
Fentanyl—CYP3A7—Biological oxidations—CYP3A4—bone cancer	1.83e-05	0.00559	CbGpPWpGaD
Fentanyl—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	1.8e-05	0.00551	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—GRM1—bone cancer	1.72e-05	0.00524	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—SMO—bone cancer	1.63e-05	0.00499	CbGpPWpGaD
Fentanyl—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	1.59e-05	0.00486	CbGpPWpGaD
Fentanyl—CYP3A7—Biological oxidations—GSTP1—bone cancer	1.56e-05	0.00478	CbGpPWpGaD
Fentanyl—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	1.54e-05	0.00471	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—GRM4—bone cancer	1.51e-05	0.00461	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—RGS1—bone cancer	1.51e-05	0.00461	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—SMO—bone cancer	1.43e-05	0.00437	CbGpPWpGaD
Fentanyl—OPRM1—TCR Signaling Pathway—JUN—bone cancer	1.43e-05	0.00436	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—RGS1—bone cancer	1.37e-05	0.00419	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—GRM4—bone cancer	1.37e-05	0.00419	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—GRM4—bone cancer	1.32e-05	0.00404	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—RGS1—bone cancer	1.32e-05	0.00404	CbGpPWpGaD
Fentanyl—CYP3A5—Biological oxidations—CYP3A4—bone cancer	1.32e-05	0.00404	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—GRM1—bone cancer	1.31e-05	0.004	CbGpPWpGaD
Fentanyl—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	1.3e-05	0.00398	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	1.3e-05	0.00397	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—SMO—bone cancer	1.21e-05	0.00369	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—GRM4—bone cancer	1.2e-05	0.00367	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—RGS1—bone cancer	1.2e-05	0.00367	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—GRM1—bone cancer	1.19e-05	0.00363	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—GRM1—bone cancer	1.15e-05	0.00351	CbGpPWpGaD
Fentanyl—CYP3A5—Biological oxidations—GSTP1—bone cancer	1.13e-05	0.00345	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—GRM4—bone cancer	1.12e-05	0.00342	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—RGS1—bone cancer	1.12e-05	0.00342	CbGpPWpGaD
Fentanyl—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	1.11e-05	0.00341	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	1.11e-05	0.00338	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—NDUFA12—bone cancer	1.1e-05	0.00335	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—GRM1—bone cancer	1.04e-05	0.00318	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—GRM4—bone cancer	1.02e-05	0.0031	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—RGS1—bone cancer	1.02e-05	0.0031	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	1.01e-05	0.00308	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—GRM1—bone cancer	9.7e-06	0.00296	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	9.17e-06	0.0028	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—NT5C3A—bone cancer	9.08e-06	0.00277	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	9.04e-06	0.00276	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—GRM1—bone cancer	8.8e-06	0.00269	CbGpPWpGaD
Fentanyl—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	8.57e-06	0.00262	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—GNA11—bone cancer	8.43e-06	0.00258	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—SMO—bone cancer	8.37e-06	0.00256	CbGpPWpGaD
Fentanyl—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	8.11e-06	0.00248	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—RGS1—bone cancer	8.09e-06	0.00247	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—GRM4—bone cancer	8.09e-06	0.00247	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—NDUFA12—bone cancer	7.92e-06	0.00242	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	7.66e-06	0.00234	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—GNA11—bone cancer	7.66e-06	0.00234	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—IL3—bone cancer	7.64e-06	0.00234	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	7.64e-06	0.00234	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—GNA11—bone cancer	7.39e-06	0.00226	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—SMO—bone cancer	7.34e-06	0.00224	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—GRM4—bone cancer	7.1e-06	0.00217	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—RGS1—bone cancer	7.1e-06	0.00217	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—GRM1—bone cancer	7.02e-06	0.00215	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—IL3—bone cancer	6.94e-06	0.00212	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—GNA11—bone cancer	6.71e-06	0.00205	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—IL3—bone cancer	6.7e-06	0.00205	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.6e-06	0.00202	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—NT5C3A—bone cancer	6.56e-06	0.00201	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—GNA11—bone cancer	6.25e-06	0.00191	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—SMO—bone cancer	6.2e-06	0.0019	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—GRM1—bone cancer	6.15e-06	0.00188	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IL3—bone cancer	6.09e-06	0.00186	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—RGS1—bone cancer	6e-06	0.00183	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—GRM4—bone cancer	6e-06	0.00183	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—NDUFA12—bone cancer	5.97e-06	0.00183	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	5.68e-06	0.00174	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—GNA11—bone cancer	5.67e-06	0.00173	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—IL3—bone cancer	5.66e-06	0.00173	CbGpPWpGaD
Fentanyl—CYP3A4—Biological oxidations—GSTP1—bone cancer	5.25e-06	0.00161	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—GRM1—bone cancer	5.2e-06	0.00159	CbGpPWpGaD
Fentanyl—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	5.18e-06	0.00158	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL3—bone cancer	5.14e-06	0.00157	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—NT5C3A—bone cancer	4.95e-06	0.00151	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—SMO—bone cancer	4.94e-06	0.00151	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—GNA11—bone cancer	4.52e-06	0.00138	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SMO—bone cancer	4.34e-06	0.00133	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	4.21e-06	0.00129	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ATF1—bone cancer	4.2e-06	0.00129	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL3—bone cancer	4.1e-06	0.00125	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	4.06e-06	0.00124	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ENO2—bone cancer	3.98e-06	0.00122	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—GNA11—bone cancer	3.97e-06	0.00121	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—DHFR—bone cancer	3.69e-06	0.00113	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ATF1—bone cancer	3.69e-06	0.00113	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NDUFA12—bone cancer	3.68e-06	0.00113	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SMO—bone cancer	3.66e-06	0.00112	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	3.66e-06	0.00112	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL3—bone cancer	3.6e-06	0.0011	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TGFBR2—bone cancer	3.51e-06	0.00107	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GNA11—bone cancer	3.45e-06	0.00105	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—GNA11—bone cancer	3.35e-06	0.00102	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IGF1R—bone cancer	3.3e-06	0.00101	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CYP3A4—bone cancer	3.13e-06	0.000955	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ATF1—bone cancer	3.12e-06	0.000952	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TGFBR2—bone cancer	3.07e-06	0.00094	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NT5C3A—bone cancer	3.05e-06	0.000932	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL3—bone cancer	3.04e-06	0.000929	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IGF1R—bone cancer	2.89e-06	0.000884	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.88e-06	0.00088	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ENO2—bone cancer	2.87e-06	0.000878	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GSTP1—bone cancer	2.67e-06	0.000817	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—DHFR—bone cancer	2.67e-06	0.000815	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TGFBR2—bone cancer	2.6e-06	0.000794	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GNA11—bone cancer	2.49e-06	0.000762	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IGF1R—bone cancer	2.44e-06	0.000747	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.42e-06	0.000739	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—KIT—bone cancer	2.39e-06	0.000731	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CYP3A4—bone cancer	2.26e-06	0.000691	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—BRAF—bone cancer	2.25e-06	0.000687	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—EGFR—bone cancer	2.18e-06	0.000666	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ENO2—bone cancer	2.17e-06	0.000663	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—KIT—bone cancer	2.1e-06	0.000641	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—DHFR—bone cancer	2.01e-06	0.000615	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—BRAF—bone cancer	1.97e-06	0.000603	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GSTP1—bone cancer	1.93e-06	0.000591	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—EGFR—bone cancer	1.91e-06	0.000584	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MDM2—bone cancer	1.88e-06	0.000576	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GNA11—bone cancer	1.88e-06	0.000575	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—KIT—bone cancer	1.77e-06	0.000542	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP3A4—bone cancer	1.7e-06	0.000521	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—BRAF—bone cancer	1.67e-06	0.000509	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MDM2—bone cancer	1.65e-06	0.000505	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—JUN—bone cancer	1.64e-06	0.000501	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—EGFR—bone cancer	1.62e-06	0.000494	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MMP9—bone cancer	1.59e-06	0.000487	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GSTP1—bone cancer	1.46e-06	0.000446	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—JUN—bone cancer	1.44e-06	0.000439	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MMP9—bone cancer	1.4e-06	0.000427	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MDM2—bone cancer	1.4e-06	0.000427	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PTGS2—bone cancer	1.38e-06	0.000423	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ENO2—bone cancer	1.34e-06	0.000408	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—EGFR—bone cancer	1.29e-06	0.000394	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—DHFR—bone cancer	1.24e-06	0.000379	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—JUN—bone cancer	1.21e-06	0.000371	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MMP9—bone cancer	1.18e-06	0.000361	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GNA11—bone cancer	1.16e-06	0.000354	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—EGFR—bone cancer	1.13e-06	0.000345	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TP53—bone cancer	1.08e-06	0.00033	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PTGS2—bone cancer	1e-06	0.000306	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—EGFR—bone cancer	9.54e-07	0.000292	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TP53—bone cancer	9.48e-07	0.00029	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTP1—bone cancer	8.98e-07	0.000275	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TP53—bone cancer	8.01e-07	0.000245	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PTGS2—bone cancer	7.55e-07	0.000231	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PTGS2—bone cancer	4.65e-07	0.000142	CbGpPWpGaD
